Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 242 articles: HTML format

Single Articles

December 2024
1. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
   Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
   J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204.
   PubMed    
   
   
   
2. HASLAK F, Kilic H, Sahin S, Hotaman B, et al
   Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
   J Rheumatol. 2024;51:1208-1217.
   PubMed     Abstract available
   
   
   
3. MAILLE M, Tounkara BS, Vagner D, Bagny K, et al
   Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study.
   J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661.
   PubMed     Abstract available
   
   
   November 2024
4. NAGASE FN, Fukui S, Takizawa N, Yamaguchi T, et al
   Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events.
   J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612.
   PubMed     Abstract available
   
   
   
5. PARIMI VP, Ravindran V
   Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases.
   J Rheumatol. 2024 Nov 15:jrheum.2024-0828. doi: 10.3899/jrheum.2024-0828.
   PubMed    
   
   
   
6. RANDELL RL, Reeve BB, Weitzman ER, von Scheven E, et al
   Pain Interference in Juvenile Idiopathic Arthritis.
   J Rheumatol. 2024;51:1119-1124.
   PubMed     Abstract available
   
   
   
7. IMAI Y, Ota Y, Matsumoto K, Akiyama M, et al
   Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
   J Rheumatol. 2024;51:1102-1110.
   PubMed     Abstract available
   
   
   
8. BRUNNER HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, et al
   Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
   J Rheumatol. 2024;51:1125-1134.
   PubMed     Abstract available
   
   
   
9. LIEBER SB, Young SR, Shea Y, Gottesman SP, et al
   The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives.
   J Rheumatol. 2024 Nov 1:jrheum.2024-0478. doi: 10.3899/jrheum.2024-0478.
   PubMed     Abstract available
   
   
   
10. ARDALAN K, Rider LG
    Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0951. doi: 10.3899/jrheum.2024-0951.
    PubMed     Abstract available
    
    
    
11. JIANG Y, Duarte-Garcia A, Putman M, Gazeley D, et al
    Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Nov 1:jrheum.2023-1038. doi: 10.3899/jrheum.2023-1038.
    PubMed     Abstract available
    
    
    October 2024
12. LIU X, Zhang J, Xu H, Kuang W, et al
    Epidemiological characteristics of patients with juvenile dermatomyositis in China: a multicenter study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0003. doi: 10.3899/jrheum.2024-0003.
    PubMed     Abstract available
    
    
    
13. ZAREK J, Lee J, Harakati D, Spitzer K, et al
    Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.
    J Rheumatol. 2024;51:964-972.
    PubMed     Abstract available
    
    
    
14. OCAMPO-TORRES MC, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, et al
    Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:991-996.
    PubMed     Abstract available
    
    
    
15. NIETO RE, Alarcon GS, Arnaud L, Pons-Estel GJ, et al
    Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment.
    J Rheumatol. 2024 Oct 1:jrheum.2024-0900. doi: 10.3899/jrheum.2024-0900.
    PubMed     Abstract available
    
    
    September 2024
16. VYZHGA Y, Doria AS, Feldman BM, Tse SM, et al
    Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using Low-Dose Computed Tomography.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0594. doi: 10.3899/jrheum.2024-0594.
    PubMed     Abstract available
    
    
    
17. KUWANA M, Wakasugi N, Hashida T, Uno S, et al
    Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0379. doi: 10.3899/jrheum.2024-0379.
    PubMed     Abstract available
    
    
    
18. AN J, Marwaha A, Laxer RM
    Autoinflammatory Diseases: A Review.
    J Rheumatol. 2024;51:848-861.
    PubMed     Abstract available
    
    
    August 2024
19. AIRES BP, Wobma H, Samad A, Chandler MT, et al
    Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
    J Rheumatol. 2024;51:811-817.
    PubMed     Abstract available
    
    
    
20. KARABUKAYEVA A, Hearld LR, Choi S, Singh JA, et al
    Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations.
    J Rheumatol. 2024;51:798-803.
    PubMed     Abstract available
    
    
    
21. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study.
    J Rheumatol. 2024;51:804-810.
    PubMed     Abstract available
    
    
    
22. GOLDER V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, et al
    Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:790-797.
    PubMed     Abstract available
    
    
    
23. OKITA Y, Okamoto M, Fujimoto J, Kumanogoh A, et al
    Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:832.
    PubMed    
    
    
    
24. YAMADA H, Sugiyama T, Ito Y, Toriihara A, et al
    Detection of Pancreatitis and Protein-Losing Gastroenteropathy Associated With Systemic Lupus Erythematosus by Protein Leakage Scintigraphy.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0468. doi: 10.3899/jrheum.2024-0468.
    PubMed     Abstract available
    
    
    
25. CHRISTOPHER-STINE L, Ciesluk A, Chinoy H, Goyal NA, et al
    The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Aug 1:jrheum.2023-1137. doi: 10.3899/jrheum.2023-1137.
    PubMed     Abstract available
    
    
    
26. GARG S, Plantinga LC
    A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0654. doi: 10.3899/jrheum.2024-0654.
    PubMed     Abstract available
    
    
    July 2024
27. BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al
    When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
    J Rheumatol. 2024;51:721-727.
    PubMed     Abstract available
    
    
    
28. BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al
    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
    J Rheumatol. 2024;51:708-714.
    PubMed     Abstract available
    
    
    
29. TANI C, Cardelli C, Zen M, Moroni L, et al
    Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053.
    PubMed     Abstract available
    
    
    
30. TELES MS, Brundage J, Chiang TP, Alejo JL, et al
    Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212.
    PubMed     Abstract available
    
    
    June 2024
31. UGARTE-GIL MF, Alarcon GS
    Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0502. doi: 10.3899/jrheum.2024-0502.
    PubMed     Abstract available
    
    
    
32. DHITAL R, Baer RJ, Bandoli G, Chambers C, et al
    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0306. doi: 10.3899/jrheum.2024-0306.
    PubMed     Abstract available
    
    
    
33. KOBAYASHI H, Yoshida Y, Kida T, Yajima N, et al
    Seasonal Effects on Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Multicenter Cohort Study in Japan (J-CANVAS).
    J Rheumatol. 2024;51:646-648.
    PubMed    
    
    
    
34. KWOK TSH, Zhou AL, Nguyen EL, Kwan A, et al
    Preliminary Development of a Novel Tool to Document Vessel Wall Involvement in Patients With Large-Vessel Vasculitis.
    J Rheumatol. 2024;51:637-639.
    PubMed    
    
    
    
35. MISZTAL MC, Gold N, Cao J, Diaz T, et al
    Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.
    J Rheumatol. 2024 Jun 1:jrheum.2023-1036. doi: 10.3899/jrheum.2023-1036.
    PubMed     Abstract available
    
    
    
36. SUN K, Molokwu NJ, Hanlen-Rosado E, Corneli AL, et al
    Implementation of a clinician-led medication adherence intervention among patients with systemic lupus erythematosus.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0071. doi: 10.3899/jrheum.2024-0071.
    PubMed     Abstract available
    
    
    May 2024
37. KANIECKI T, Moyers B, Lubinus M, Hu YP, et al
    Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey.
    J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108.
    PubMed     Abstract available
    
    
    
38. AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al
    A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
    J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114.
    PubMed     Abstract available
    
    
    
39. AVASARALA J, Das S, Keshavamurthy S
    Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale.
    J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217.
    PubMed     Abstract available
    
    
    
40. BRIDGES JM, Li J, Mannion ML, Clowse MEB, et al
    Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry.
    J Rheumatol. 2024;51:542-545.
    PubMed    
    
    
    April 2024
41. SEMALULU T, Berard R, Beattie K, Basodan D, et al
    Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
    J Rheumatol. 2024;51:403-407.
    PubMed     Abstract available
    
    
    
42. OWN M, Bloostein A, Spiera R, Berman JR, et al
    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
    J Rheumatol. 2024;51:390-395.
    PubMed     Abstract available
    
    
    
43. CONTRERAS MARTIN GN
    Lupus Nephritis Treatment Strategies.
    J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
    PubMed     Abstract available
    
    
    
44. JUNEK M, Barra L, Kopp A, Felfeli T, et al
    Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
    PubMed     Abstract available
    
    
    
45. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
    Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
    PubMed     Abstract available
    
    
    March 2024
46. YAMAMOTO H, Taniguchi Y
    Cranial Giant Cell Arteritis and Subdural Hematoma.
    J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
    PubMed     Abstract available
    
    
    
47. YENNEMADI AS, Jordan N, Diong S, Keane J, et al
    The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases.
    J Rheumatol. 2024;51:234-241.
    PubMed     Abstract available
    
    
    
48. FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al
    The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
    J Rheumatol. 2024;51:297-304.
    PubMed     Abstract available
    
    
    
49. YASUDA N, Yamane T
    Leg Gangrene in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:316-317.
    PubMed    
    
    
    
50. PATEL NJ, Wang X, Lin M, Kowalski EN, et al
    Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092.
    PubMed     Abstract available
    
    
    
51. DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al
    Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3 Palsy in Giant Cell Arteritis.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195.
    PubMed     Abstract available
    
    
    
52. MORAND EF, Jones SA
    Flare in Systemic Lupus Erythematosus: Lost in Translation?
    J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122.
    PubMed     Abstract available
    
    
    February 2024
53. TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al
    Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis in Japan: 10-year analysis of the real-world TRUST study.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210.
    PubMed     Abstract available
    
    
    
54. WALSH M, Strouse J, Bettendorf B
    Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
    J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160.
    PubMed     Abstract available
    
    
    
55. SAGY I, Schwarzfuchs O, Zeller L, Ling E, et al
    Short- and Long-Term Mortality of Hospitalized Patients with Autoimmune Rheumatic Diseases and Serious Infections: A National Cohort Study.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1063. doi: 10.3899/jrheum.2023-1063.
    PubMed     Abstract available
    
    
    
56. ALPERS CE
    Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
    J Rheumatol. 2024;51:109-111.
    PubMed    
    
    
    
57. PEDERSEN MJ, Host C, Hansen SN, Deleuran BW, et al
    Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic Arthritis: A National Matched Cohort Study.
    J Rheumatol. 2024;51:181-188.
    PubMed     Abstract available
    
    
    December 2023
58. ROGERS JL, Clowse MEB, McKenna K, Starling S, et al
    Patient and physician perspectives of systemic lupus erythematosus flare: A qualitative study.
    J Rheumatol. 2023 Dec 15:jrheum.2023-0721. doi: 10.3899/jrheum.2023-0721.
    PubMed     Abstract available
    
    
    
59. SKYDEL JJ, Ramachandran R, Suttiratana S, Ross JS, et al
    Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies.
    J Rheumatol. 2023 Dec 15:jrheum.2023-0920. doi: 10.3899/jrheum.2023-0920.
    PubMed     Abstract available
    
    
    November 2023
60. TOUMA Z, Parodis I, Strand V
    More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0947. doi: 10.3899/jrheum.2023-0947.
    PubMed     Abstract available
    
    
    
61. RUBENSTEIN E, Maldini C, Vaglio A, Bello F, et al
    Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2023;50:1446-1453.
    PubMed     Abstract available
    
    
    
62. ROZENBLYUM EV, Chan MO, Gakhal NK
    Chew on This: The Afterbite of Temporomandibular Joint Involvement in Adults With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2023;50:1364-1366.
    PubMed    
    
    
    
63. RUPERTO N, Lovell DJ, Berman A, Anton J, et al
    Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
    J Rheumatol. 2023;50:1471-1480.
    PubMed     Abstract available
    
    
    
64. DE SONNAVILLE WFC, Speksnijder CM, Zuithoff NPA, Heijstek MW, et al
    Clinically Established Temporomandibular Involvement in Adults With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2023;50:1462-1470.
    PubMed     Abstract available
    
    
    
65. OGURO N, Yajima N, Ishikawa Y, Sakurai N, et al
    Impact of Attending Rheumatologist's Big Five Personality Traits on Systemic Lupus Erythematosus Patients' Trust: The TRUMP2-SLE Project.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0603. doi: 10.3899/jrheum.2023-0603.
    PubMed     Abstract available
    
    
    October 2023
66. SUN YS, Huang DF, Chen WS, Liao HT, et al
    Risk factor and incidence of serious infections in systemic lupus erythematosus patients undergoing rituximab therapy.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0623. doi: 10.3899/jrheum.2023-0623.
    PubMed     Abstract available
    
    
    
67. PARREAU S, Dumonteil S, Gondran G, Bezanahary H, et al
    Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 Patients.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0358. doi: 10.3899/jrheum.2023-0358.
    PubMed     Abstract available
    
    
    
68. KAWANO Y, Wang X, Patel NJ, Qian G, et al
    Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.
    PubMed     Abstract available
    
    
    
69. NIETO-GONZALEZ JC, Garulo DC, Boteanu A, Trives-Folguera L, et al
    What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?
    J Rheumatol. 2023;50:1326-1332.
    PubMed     Abstract available
    
    
    
70. AGUIRRE A, DeQuattro K, Shiboski S, Katz P, et al
    Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2023;50:1302-1309.
    PubMed     Abstract available
    
    
    
71. LIU S, Han L, Li M, Tian X, et al
    Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
    J Rheumatol. 2023;50:1318-1325.
    PubMed     Abstract available
    
    
    
72. QUINTANA R, Ramirez-Flores MF, Fuentes-Silva Y, Pelaez-Ballestas I, et al
    Diagnostic Delay in Autoimmune Rheumatic Diseases: A Global Health Problem.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0847. doi: 10.3899/jrheum.2023-0847.
    PubMed     Abstract available
    
    
    September 2023
73. PESKIN M, Mostowy M, Velez J, Perron M, et al
    Clinical improvement in early onset interstitial lung disease using rituximab in children with anti-MDA5 positive juvenile dermatomyositis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0544. doi: 10.3899/jrheum.2023-0544.
    PubMed     Abstract available
    
    
    
74. SASAI T, Nakashima R, Tsuji H, Nakajima T, et al
    Long term prognosis of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0371. doi: 10.3899/jrheum.2023-0371.
    PubMed     Abstract available
    
    
    
75. YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al
    Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    J Rheumatol. 2023;50:1152-1158.
    PubMed     Abstract available
    
    
    
76. WEISS PF, Brandon TG, Lambert RG, Biko DM, et al
    Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis.
    J Rheumatol. 2023;50:1173-1177.
    PubMed     Abstract available
    
    
    
77. MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al
    Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
    J Rheumatol. 2023;50:1145-1151.
    PubMed     Abstract available
    
    
    
78. FERUCCI ED
    Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.
    J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772.
    PubMed     Abstract available
    
    
    August 2023
79. BERMAS BL, Sammaritano LR
    Complementing What We Know About Systemic Lupus Erythematosus Pregnancy.
    J Rheumatol. 2023 Aug 15:jrheum.2023-0432. doi: 10.3899/jrheum.2023-0432.
    PubMed     Abstract available
    
    
    
80. XIANG L, Yoon S, Low AHL, Leung YY, et al
    Symptom Appraisal and Help-seeking among Patients with Autoimmune Rheumatic Diseases: A Qualitative Study.
    J Rheumatol. 2023 Aug 15:jrheum.2023-0086. doi: 10.3899/jrheum.2023-0086.
    PubMed     Abstract available
    
    
    
81. LINDE L, Faurschou M, Krintel SB, Baslund B, et al
    Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis.
    J Rheumatol. 2023;50:1088-1089.
    PubMed    
    
    
    
82. ROBERTS JE, Williams K, Dallas J, Eckert M, et al
    Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry.
    J Rheumatol. 2023;50:1047-1057.
    PubMed     Abstract available
    
    
    July 2023
83. YEUNG RSM
    What's in a Name? That Which We Call JIA, by Any Other Name, Would It Still Be the Same Childhood Arthritis?
    J Rheumatol. 2023;50.
    PubMed     Abstract available
    
    
    
84. 
    Canadian Rheumatology Association Meeting Quebec City Convention Centre Quebec City, Quebec, Canada February 8-11, 2023.
    J Rheumatol. 2023;50.
    PubMed     Abstract available
    
    
    
85. TANI C, Zucchi D, Bellis E, Birru Talabi M, et al
    Patient Care Pathways for Pregnancy in Rare and Complex Rheumatic Diseases: Results From an International Survey.
    J Rheumatol. 2023;50:934-938.
    PubMed     Abstract available
    
    
    
86. LONDE AC, Ruiz RF, Julio PR, Appenzeller S, et al
    Type I Interferons in autoimmunity: implications in clinical phenotypes and treatment response.
    J Rheumatol. 2023 Jul 1:jrheum.2022-0827. doi: 10.3899/jrheum.2022-0827.
    PubMed     Abstract available
    
    
    
87. KASTURI S, Ahearn EL, Batterman A, Horton R, et al
    Measuring what matters: a qualitative study of the relevance and clinical utility of PROMIS(R) surveys in systemic lupus erythematosus.
    J Rheumatol. 2023 Jul 1:jrheum.2023-0184. doi: 10.3899/jrheum.2023-0184.
    PubMed     Abstract available
    
    
    
88. BARBHAIYA M, Taghavi M, Zuily S, Domingues V, et al
    Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the New Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report.
    J Rheumatol. 2023 Jul 1:jrheum.2022-1200. doi: 10.3899/jrheum.2022-1200.
    PubMed     Abstract available
    
    
    June 2023
89. OYAMA M, Ohnuki Y, Uruha A, Saito Y, et al
    Association between HLA alleles and autoantibodies in dermatomyositis defined by sarcoplasmic expression of myxovirus resistance protein A.
    J Rheumatol. 2023 Jun 15:jrheum.2022-1321. doi: 10.3899/jrheum.2022-1321.
    PubMed     Abstract available
    
    
    
90. SAMEC MJ, Rakholiya J, Langenfeld H, Crowson CS, et al
    Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study.
    J Rheumatol. 2023 Jun 15:jrheum.2022-1214. doi: 10.3899/jrheum.2022-1214.
    PubMed     Abstract available
    
    
    
91. MOK CC
    Prognostic Stratification of Lupus Nephritis: The Importance of Renal Histology.
    J Rheumatol. 2023 Jun 1:jrheum.2023-0381. doi: 10.3899/jrheum.2023-0381.
    PubMed     Abstract available
    
    
    
92. GOULENOK T, Mendes C, Dayan L, Ferre VM, et al
    Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Jun 1:jrheum.2022-1335. doi: 10.3899/jrheum.2022-1335.
    PubMed     Abstract available
    
    
    
93. LI L, Merchant M, Gordon S, Lang B, et al
    High Rates of Symptoms of Major Depressive Disorder and Panic Disorder in a Canadian Sample of Adolescents With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2023;50:804-808.
    PubMed     Abstract available
    
    
    
94. FRENKEL Y, Kraushar I, Saied MH, Haviv R, et al
    Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis: A Nationwide Israeli Retrospective Study.
    J Rheumatol. 2023;50:799-803.
    PubMed     Abstract available
    
    
    
95. BOLETO G, Berti A, Merkel PA, Aydin SZ, et al
    Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review.
    J Rheumatol. 2023;50:789-798.
    PubMed     Abstract available
    
    
    May 2023
96. BATE S, Brix SR
    From Prediction Tools to Precision Medicine in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    J Rheumatol. 2023;50:583-585.
    PubMed    
    
    
    
97. HIMMEL M, Balter M, Ahmad Z, Bangert E, et al
    Epidemiology and Survival of Systemic Sclerosis-Sarcoidosis Overlap Syndrome.
    J Rheumatol. 2023;50:656-661.
    PubMed     Abstract available
    
    
    
98. NI A, Chen L, Lan L, Wang Y, et al
    Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.
    J Rheumatol. 2023;50:662-670.
    PubMed     Abstract available
    
    
    
99. STOUSTRUP P, Rahimi H, Twilt M, Goh YI, et al
    Assessment of Orofacial Symptoms in Juvenile Idiopathic Arthritis: Validation of a Consensus-Based Short Patient Questionnaire.
    J Rheumatol. 2023;50:676-683.
    PubMed     Abstract available
    
    
    
100. MISZTAL MC, Liao F, Couse M, Cao J, et al
     Genome-Wide Sequencing Identified Rare Genetic Variants for Childhood-Onset Monogenic Lupus.
     J Rheumatol. 2023;50:671-675.
     PubMed     Abstract available
     
     
     
101. WANG G, Zhuo N, Wen Z
     IgG4-Related Disease With Testicular Involvement: Association or Coincidence?
     J Rheumatol. 2023;50:715.
     PubMed    
     
     
     
102. TADA N, Nobuyuki Y, Konishi N, Shiozawa E, et al
     Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule.
     J Rheumatol. 2023;50:707-708.
     PubMed    
     
     
     
103. MOADAB F, Wang X, Najjar R, Ukadike KC, et al
     Argonaute, vault, and ribosomal proteins targeted by autoantibodies in systemic lupus erythematosus.
     J Rheumatol. 2023 May 1:jrheum.2022-1327. doi: 10.3899/jrheum.2022-1327.
     PubMed     Abstract available
     
     
     
104. CRISAFULLI F, Andreoli L, Zucchi D, Reggia R, et al
     Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes.
     J Rheumatol. 2023 May 1:jrheum.2022-1135. doi: 10.3899/jrheum.2022-1135.
     PubMed     Abstract available
     
     
     
105. CORBITT K, Izmirly P, Saxena A
     Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2.
     J Rheumatol. 2023 May 1:jrheum.2023-0205. doi: 10.3899/jrheum.2023-0205.
     PubMed     Abstract available
     
     
     April 2023
106. SRINIVASALU H, Treemarcki EB, Rumsey DG, Weiss PF, et al
     Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
     J Rheumatol. 2023;50:532-537.
     PubMed     Abstract available
     
     
     
107. LIAO YW, Chen YM, Hsieh TY, Hung WT, et al
     Renal Histopathology Associated with Kidney Failure and Mortality in 526 Lupus Nephritis Patients, a Long-Term Realworld Data Study.
     J Rheumatol. 2023 Apr 1:jrheum.220345. doi: 10.3899/jrheum.220345.
     PubMed     Abstract available
     
     
     
108. CINTRA FRE, Araujo LM, Dib MI, Brollo LCS, et al
     Cervical Cancer Screening Is a Highly Neglected Procedure Among Women With Systemic Lupus Erythematosus.
     J Rheumatol. 2023 Apr 1:jrheum.230082. doi: 10.3899/jrheum.230082.
     PubMed     Abstract available
     
     
     March 2023
109. SCHULTZ K, Jannat-Khah D, Spiera R
     B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab.
     J Rheumatol. 2023;50:420-425.
     PubMed     Abstract available
     
     
     
110. ANGELES-HAN ST, Srivastava SK
     Screening, Monitoring, and Treating Children With Juvenile Idiopathic Arthritis-associated Uveitis: Visualizing Better Outcomes.
     J Rheumatol. 2023;50:300-303.
     PubMed    
     
     
     
111. BAKER MC, Cook C, Fu X, Perugino CA, et al
     The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease.
     J Rheumatol. 2023;50:408-412.
     PubMed     Abstract available
     
     
     
112. BERARD R, Ng HY, Human A, Piskin D, et al
     Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
     J Rheumatol. 2023;50:390-399.
     PubMed     Abstract available
     
     
     
113. KROL RM, Schaap CM, Welsing PMJ, Klaasen R, et al
     Immunosuppressive Therapies in Ear, Nose, and Throat Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results From a Multicenter Retrospective Cohort Study.
     J Rheumatol. 2023;50:384-389.
     PubMed     Abstract available
     
     
     February 2023
114. SUN K, Coles TM, Voils CI, Anderson DR, et al
     Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence.
     J Rheumatol. 2023;50:296.
     PubMed    
     
     
     
115. AHMED S, Misra R
     Microdissecting Epigenetic Pathways in Oligoarticular Juvenile Idiopathic Arthritis: A New Avenue in Transforming Growth Factor beta?
     J Rheumatol. 2023;50:164-165.
     PubMed    
     
     
     
116. PYO JY, Ahn SS, Song JJ, Park YB, et al
     The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
     J Rheumatol. 2023;50:213-218.
     PubMed     Abstract available
     
     
     
117. MCALPINE SM, Roberts SE, Hargreaves BKV, Bullock C, et al
     Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis.
     J Rheumatol. 2023;50:227-235.
     PubMed     Abstract available
     
     
     January 2023
118. MAJEROVICH K, Junek M, Khalidi N, Garner S, et al
     Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study.
     J Rheumatol. 2023 Jan 15:jrheum.220860. doi: 10.3899/jrheum.220860.
     PubMed     Abstract available
     
     
     
119. JAVA A, Kim AHJ
     The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics.
     J Rheumatol. 2023 Jan 15:jrheum.220752. doi: 10.3899/jrheum.220752.
     PubMed     Abstract available
     
     
     
120. COOK C, Patel NJ, Fu X, Wang X, et al
     Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications.
     J Rheumatol. 2023 Jan 15:jrheum.220870. doi: 10.3899/jrheum.220870.
     PubMed     Abstract available
     
     
     
121. SMITHERMAN EA, Chahine RA, Bitencourt N, Rahman AKMF, et al
     Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
     J Rheumatol. 2023;50:98-106.
     PubMed     Abstract available
     
     
     
122. HU W, Ma Y, Wang P, Xu AE, et al
     A Case of Rowell Syndrome Manifested on Hands: Targetoid-like Lesions and Nailfold Capillaries.
     J Rheumatol. 2023;50:147.
     PubMed    
     
     
     December 2022
123. ELFISHAWI M, Rakholiya J, Gunderson TM, Achenbach SJ, et al
     Lower frequency of comorbidities prior to onset of giant cell arteritis; a population-based study.
     J Rheumatol. 2022 Dec 15:jrheum.220610. doi: 10.3899/jrheum.220610.
     PubMed     Abstract available
     
     
     
124. GEROLYMATOU N, Bakasis AD, Voulgari PV, Vlachoyiannopoulos PG, et al
     Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases.
     J Rheumatol. 2022 Dec 15:jrheum.221014. doi: 10.3899/jrheum.221014.
     PubMed     Abstract available
     
     
     
125. JORGE AM
     Burden of Comorbidities Predicts 30-Day Rehospitalizations in Young Adult Medicare Beneficiaries With Systemic Lupus Erythematosus.
     J Rheumatol. 2022 Dec 1:jrheum.221125. doi: 10.3899/jrheum.221125.
     PubMed     Abstract available
     
     
     
126. NAGAHATA K, Sugawara M, Kanda M, Takahashi H, et al
     Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis.
     J Rheumatol. 2022 Dec 1:jrheum.220649. doi: 10.3899/jrheum.220649.
     PubMed     Abstract available
     
     
     
127. JEANTIN L, Lenfant T, Bataille P, de Boysson H, et al
     Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature.
     J Rheumatol. 2022;49:1349-1355.
     PubMed     Abstract available
     
     
     
128. SUGAWARA E, Sato T, Katsumata K
     IgG4-related Disease Mimicking a Paratesticular Tumor and Pelvic Lymph Node Metastasis.
     J Rheumatol. 2022;49:1396-1397.
     PubMed    
     
     
     
129. TANOMOGI N, Kubota M, Kato M
     Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis.
     J Rheumatol. 2022;49:1395.
     PubMed    
     
     
     November 2022
130. FIGUEROA-PARRA G, Jeffery MM, Dabit JY, Chevet B, et al
     Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study.
     J Rheumatol. 2022 Nov 15. pii: jrheum.220822. doi: 10.3899/jrheum.220822.
     PubMed     Abstract available
     
     
     
131. OGURO N, Yajima N, Miyawaki Y, Yoshimi R, et al
     Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP(2)-SLE project.
     J Rheumatol. 2022 Nov 15. pii: jrheum.220678. doi: 10.3899/jrheum.220678.
     PubMed     Abstract available
     
     
     
132. YOSHINARI M, Hattanda F, Nishibata Y, Masuda S, et al
     A Novel Antineutrophil Extracellular Trap Antibody Targeting Myosin Light Chain 6 in Microscopic Polyangiitis.
     J Rheumatol. 2022;49:1286-1288.
     PubMed    
     
     
     
133. JOHNSON SR, Martinez JPD, Whittall-Garcia L, Urowitz MB, et al
     Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria.
     J Rheumatol. 2022 Nov 1. pii: jrheum.220100. doi: 10.3899/jrheum.220100.
     PubMed     Abstract available
     
     
     
134. ZHUO N, Wang G, Li J, Liu Y, et al
     Systemic Lupus Erythematosus Flares During Dialysis in Patients With Endstage Renal Disease.
     J Rheumatol. 2022 Nov 1. pii: jrheum.220947. doi: 10.3899/jrheum.220947.
     PubMed     Abstract available
     
     
     
135. SEO P, Winthrop K, Sawalha AH, Choi S, et al
     Physicians' perspective on vaccination in patients with autoimmune inflammatory rheumatic diseases: an international survey.
     J Rheumatol. 2022 Nov 1. pii: jrheum.220135. doi: 10.3899/jrheum.220135.
     PubMed     Abstract available
     
     
     October 2022
136. DUARTE GARCIA A, Yazdany J
     Cardiovascular Disease Disparities in Systemic Lupus Erythematosus.
     J Rheumatol. 2022 Oct 15. pii: jrheum.220933. doi: 10.3899/jrheum.220933.
     PubMed     Abstract available
     
     
     
137. ALHAMMADI NA, Gladman DD, Su J, Urowitz MB, et al
     Isolated Neutropenia in Systemic Lupus Erythematosus.
     J Rheumatol. 2022 Oct 15. pii: jrheum.220373. doi: 10.3899/jrheum.220373.
     PubMed     Abstract available
     
     
     
138. SCHULERT GS
     The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.
     J Rheumatol. 2022;49:1082-1084.
     PubMed    
     
     
     
139. LAHIRY P, Naumenko S, Couse M, Liao F, et al
     Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome.
     J Rheumatol. 2022;49:1146-1151.
     PubMed     Abstract available
     
     
     
140. TOLLISEN A, Selvaag AM, Aasland A, Ingebrigtsen T, et al
     Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2022;49:1138-1145.
     PubMed     Abstract available
     
     
     
141. VEGA-FERNANDEZ P, Esteban Y, Oberle E, Proulx-Gauthier JP, et al
     Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist and Finger Joints.
     J Rheumatol. 2022 Oct 1. pii: jrheum.220382. doi: 10.3899/jrheum.220382.
     PubMed     Abstract available
     
     
     September 2022
142. DAVIS A, Faerber J, Ardalan K, Katcoff H, et al
     The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Newly Diagnosed Systemic Lupus Erythematosus.
     J Rheumatol. 2022 Sep 15. pii: jrheum.220052. doi: 10.3899/jrheum.220052.
     PubMed     Abstract available
     
     
     
143. STULL C, Sprow G, Werth VP
     Cutaneous Involvement in Systemic Lupus Erythematous: A Review for the Rheumatologist.
     J Rheumatol. 2022 Sep 15. pii: jrheum.220089. doi: 10.3899/jrheum.220089.
     PubMed     Abstract available
     
     
     
144. XU A, Chen J, Wang X, Ye S, et al
     Pneumomediastinum and Subcutaneous Facial Emphysema in Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
     J Rheumatol. 2022 Sep 15. pii: jrheum.220521. doi: 10.3899/jrheum.220521.
     PubMed     Abstract available
     
     
     
145. MARTINEZ PEREZ JM, Mollerach FB, Scaglioni V, Vergara F, et al
     Incidence and Prevalence of Polymyalgia Rheumatica and Giant Cell Arteritis in a Healthcare Management Organization in Buenos Aires, Argentina.
     J Rheumatol. 2022 Sep 1. pii: jrheum.220084. doi: 10.3899/jrheum.220084.
     PubMed     Abstract available
     
     
     
146. SUN K, Coles TM, Voils CI, Anderson DR, et al
     Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of Extent of and Reasons for Medication Nonadherence.
     J Rheumatol. 2022 Sep 1. pii: jrheum.220399. doi: 10.3899/jrheum.220399.
     PubMed     Abstract available
     
     
     
147. SEVIM E, Siddique S, Chalasani MLS, Chyou S, et al
     Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo.
     J Rheumatol. 2022;49:1026-1030.
     PubMed     Abstract available
     
     
     
148. SHOOP-WORRALL SJW, Moull L, McDonagh JE, Hyrich KL, et al
     The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis.
     J Rheumatol. 2022;49:1037-1041.
     PubMed     Abstract available
     
     
     August 2022
149. CHUNG SH, Oshima K, Singleton M, Thomason J, et al
     Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus.
     J Rheumatol. 2022 Aug 15. pii: jrheum.220105. doi: 10.3899/jrheum.220105.
     PubMed     Abstract available
     
     
     
150. KIM YE, Choi SJ, Lim DH, Kim H, et al
     Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis.
     J Rheumatol. 2022 Aug 15. pii: jrheum.220101. doi: 10.3899/jrheum.220101.
     PubMed     Abstract available
     
     
     
151. SCHLETZBAUM M, Kind AJ, Chen Y, Astor BC, et al
     Age-Stratified Thirty-Day Rehospitalization and Mortality and Predictors of Rehospitalization among Patients with Systemic Lupus Erythematosus: a Medicare cohort study.
     J Rheumatol. 2022 Aug 15. pii: jrheum.220025. doi: 10.3899/jrheum.220025.
     PubMed     Abstract available
     
     
     
152. MATSUDA S, Kotani T, Kuwabara H, Suzuka T, et al
     Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease.
     J Rheumatol. 2022;49:913-921.
     PubMed     Abstract available
     
     
     
153. TREFOND L, Sauret A, Stievenart J, Olagne L, et al
     Dr. Trefond et al reply: Giant Cell Arteritis After SARS-CoV-2 Vaccination-Coincidence or Trigger ?
     J Rheumatol. 2022;49:964.
     PubMed    
     
     
     
154. KALLAS R, Li J, Goldman DW, Magder LS, et al
     Trajectory of Damage Accrual in Systemic Lupus Erythematosus based on Ethnicity and Socioeconomic Factors.
     J Rheumatol. 2022 Aug 1. pii: jrheum.211135. doi: 10.3899/jrheum.211135.
     PubMed     Abstract available
     
     
     
155. GARG S, Bartels CM, Bao G, Helmick CG, et al
     Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
     J Rheumatol. 2022 Aug 1. pii: jrheum.220279. doi: 10.3899/jrheum.220279.
     PubMed     Abstract available
     
     
     
156. NOZAWA T, Bell-Peter A, Marcuz JA, Whitney K, et al
     Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis.
     J Rheumatol. 2022 Aug 1. pii: jrheum.220249. doi: 10.3899/jrheum.220249.
     PubMed     Abstract available
     
     
     July 2022
157. 
     Canadian Rheumatology Association Annual Meeting, February 2-5, 2022.
     J Rheumatol. 2022;49:751-847.
     PubMed     Abstract available
     
     
     
158. LOIZIDIS G, Rabinowitz MR, Tuluc M
     IgG4-related Disease With Destructive Nasal Bone Involvement Leading to Saddle Nose Deformity.
     J Rheumatol. 2022;49:748-749.
     PubMed    
     
     
     
159. MIRESKANDARI K
     Uveitis in Juvenile Psoriatic Arthritis: Still So Much To Learn.
     J Rheumatol. 2022;49:661-662.
     PubMed    
     
     
     
160. BAQUET-WALSCHEID K, Rothaus K, Niewerth M, Klotsche J, et al
     Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany.
     J Rheumatol. 2022;49:719-724.
     PubMed     Abstract available
     
     
     
161. TREFOND L, Sauret A, Stievenart J, Olagne L, et al
     Dr. Trefond et al reply: Giant Cell Arteritis After SARS-CoV-2 Vaccination-Coincidence or Trigger?
     J Rheumatol. 2022;49:860.
     PubMed    
     
     
     
162. CHEVET B, Figueroa-Parra G, Yang JX, Hulshizer CA, et al
     COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
     J Rheumatol. 2022 Jul 1. pii: jrheum.220220. doi: 10.3899/jrheum.220220.
     PubMed     Abstract available
     
     
     June 2022
163. LV C, You H, Xu L, Wang L, et al
     Coexisting of anti-Ro52 autoantibodies on anti-MDA5 autoantibodies-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk.
     J Rheumatol. 2022 Jun 15. pii: jrheum.220139. doi: 10.3899/jrheum.220139.
     PubMed     Abstract available
     
     
     
164. SIMONS G, Falahee M
     Fear of the Unknown: Can We Help Individuals With a Systemic Autoimmune Rheumatic Disease Deal With Uncertainty?
     J Rheumatol. 2022 Jun 1. pii: jrheum.220502. doi: 10.3899/jrheum.220502.
     PubMed     Abstract available
     
     
     
165. MARINO A, Orsini F, Pregnolato F, Cimaz R, et al
     Tumor Necrosis Factor-alpha Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
     J Rheumatol. 2022;49:654-656.
     PubMed    
     
     
     
166. BOLHUIS TE, Nizet LEA, Owen C, den Broeder AA, et al
     Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
     J Rheumatol. 2022;49:627-634.
     PubMed     Abstract available
     
     
     
167. MAHESWARANATHAN M, Eudy AM, Barr AC, Howe C, et al
     Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test.
     J Rheumatol. 2022;49:585-591.
     PubMed     Abstract available
     
     
     May 2022
168. MINIAOUI I, Morel N, Levesque K, Maltret A, et al
     Health Outcome of 215 Mothers of Children with Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry.
     J Rheumatol. 2022 May 2. pii: jrheum.210703. doi: 10.3899/jrheum.210703.
     PubMed     Abstract available
     
     
     
169. MCHUGH A, Chan A, Herrera C, Park JM, et al
     Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis.
     J Rheumatol. 2022;49:489-496.
     PubMed     Abstract available
     
     
     
170. EL TAL T, Ryan ME, Feldman BM, Bingham CA, et al
     Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.
     J Rheumatol. 2022;49:497-503.
     PubMed     Abstract available
     
     
     April 2022
171. LALLY L, Narula N, Goodfellow N, Luqmani R, et al
     Rho Kinase Expression in Giant Cell Arteritis: Validating pERM Intensity Score to Increase Sensitivity of Temporal Artery Biopsy.
     J Rheumatol. 2022 Apr 15. pii: jrheum.220012. doi: 10.3899/jrheum.220012.
     PubMed     Abstract available
     
     
     
172. KUWANA M, Wakasugi N, Furuya T, Uno S, et al
     Tacrolimus in patients with interstitial pneumonia associated with polymyositis or dermatomyositis: interim report of post-marketing surveillance in Japan.
     J Rheumatol. 2022 Apr 15. pii: jrheum.210322. doi: 10.3899/jrheum.210322.
     PubMed     Abstract available
     
     
     
173. WALLACE ZS, Cook C, Finkelstein-Fox L, Fu X, et al
     The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases.
     J Rheumatol. 2022 Apr 1. pii: jrheum.211084. doi: 10.3899/jrheum.211084.
     PubMed     Abstract available
     
     
     
174. NOONE DG, Silverman ED
     Treatment of Childhood-onset Proliferative Lupus Nephritis in the 21st Century: A Call to Catch Up With the Evidence.
     J Rheumatol. 2022 Apr 1. pii: jrheum.220196. doi: 10.3899/jrheum.220196.
     PubMed     Abstract available
     
     
     
175. GIANCANE G, Papa R, Vastert S, Bagnasco F, et al
     Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
     J Rheumatol. 2022;49:398-407.
     PubMed     Abstract available
     
     
     March 2022
176. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
     Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
     J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
     PubMed     Abstract available
     
     
     
177. HADWEN B, Yu R, Cairns E, Barra L, et al
     Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
     J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
     PubMed     Abstract available
     
     
     
178. LIU Y, Xiao F, Zhang R, Zhang X, et al
     Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
     J Rheumatol. 2022 Mar 15. pii: jrheum.220023. doi: 10.3899/jrheum.220023.
     PubMed     Abstract available
     
     
     
179. SUN G, Yafasova A, Baslund B, Faurschou M, et al
     Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study.
     J Rheumatol. 2022;49:291-298.
     PubMed     Abstract available
     
     
     February 2022
180. JAMES W, Ogunrinde E, Wan Z, Kamen DL, et al
     A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals.
     J Rheumatol. 2022 Feb 15. pii: jrheum.210952. doi: 10.3899/jrheum.210952.
     PubMed     Abstract available
     
     
     
181. CANNON L, Wenderfer SE, Lewandowski LB, Cooper JC, et al
     Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America.
     J Rheumatol. 2022 Feb 15. pii: jrheum.210428. doi: 10.3899/jrheum.210428.
     PubMed     Abstract available
     
     
     
182. CHANG Y, Di W, Wu J
     Systemic Lupus Erythematosus Increases the Risk of Gestational Diabetes: Truth or Illusion?
     J Rheumatol. 2022 Feb 1. pii: jrheum.211374. doi: 10.3899/jrheum.211374.
     PubMed     Abstract available
     
     
     
183. PEREZ ACOSTA ME, Meyers AB, Toth MB
     Cystic Ganglionosis in a 3-year-old Mimicking Juvenile Idiopathic Arthritis.
     J Rheumatol. 2022;49:230-231.
     PubMed    
     
     
     January 2022
184. FAIR DC, Nocton JJ, Panepinto JA, Yan K, et al
     Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures.
     J Rheumatol. 2022;49:74-80.
     PubMed     Abstract available
     
     
     December 2021
185. LI Z, Li D, Lv P, Liu J, et al
     Brain Abscess Due to Nocardia in a Patient With Systemic Lupus Erythematosus.
     J Rheumatol. 2021 Dec 1. pii: jrheum.210971. doi: 10.3899/jrheum.210971.
     PubMed     Abstract available
     
     
     
186. VAN VOLLENHOVEN RF, Hahn BH, Tsokos GC, Lipsky P, et al
     Efficacy and Safety of Ustekinumab in Patients with Active Systemic Lupus Erythematosus: Results Through 2 Years of an Open-Label Extension in a Phase 2 Study.
     J Rheumatol. 2021 Dec 1. pii: jrheum.210805. doi: 10.3899/jrheum.210805.
     PubMed     Abstract available
     
     
     
187. GERNAAT SAM, Simard JF, Wikstrom AK, Svenungsson E, et al
     Gestational Diabetes Mellitus Risk in Pregnant Women with Systemic Lupus Erythematosus.
     J Rheumatol. 2021 Dec 1. pii: jrheum.210087. doi: 10.3899/jrheum.210087.
     PubMed     Abstract available
     
     
     
188. TOUSSIROT E, Michaud M, Wendling D, Devauchelle V, et al
     Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica.
     J Rheumatol. 2021;48:1888-1889.
     PubMed    
     
     
     
189. DAVE I, Estroff B, Gergely T, Rostad CA, et al
     Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
     J Rheumatol. 2021;48:1856-1862.
     PubMed     Abstract available
     
     
     
190. AESCHLIMANN FA, Raimondi F, Leiner T, Aquaro GD, et al
     Overview of imaging in adult- and childhood-onset Takayasu arteritis.
     J Rheumatol. 2021 Dec 1. pii: jrheum.210368. doi: 10.3899/jrheum.210368.
     PubMed     Abstract available
     
     
     November 2021
191. IWAMOTO T, Dorschner JM, Selvaraj S, Mezzano V, et al
     High Systemic Type I Interferon Activity is Associated with Active Class III/IV Lupus Nephritis.
     J Rheumatol. 2021 Nov 15. pii: jrheum.210391. doi: 10.3899/jrheum.210391.
     PubMed     Abstract available
     
     
     
192. CURTIS JR, Zhou X, Rubin DT, Reinisch W, et al
     Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study.
     J Rheumatol. 2021 Nov 15. pii: jrheum.210888. doi: 10.3899/jrheum.210888.
     PubMed     Abstract available
     
     
     
193. WOJCIK S, Inman RD, Nakamura A
     IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis.
     J Rheumatol. 2021;48:1757-1758.
     PubMed    
     
     
     
194. MENDEL A, Pagnoux C
     Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020.
     J Rheumatol. 2021;48:1755-1756.
     PubMed    
     
     
     
195. SPRINGER JM, Funk RS
     Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
     J Rheumatol. 2021;48:1718-1724.
     PubMed     Abstract available
     
     
     
196. BERARD R, Batthish M
     Addressing Healthcare Quality in Juvenile Idiopathic Arthritis With a Universal Access Program.
     J Rheumatol. 2021;48:1635-1638.
     PubMed    
     
     
     
197. CONCHA S, Morales PS, Talesnik E, Borzutzky A, et al
     Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis.
     J Rheumatol. 2021;48:1725-1731.
     PubMed     Abstract available
     
     
     October 2021
198. CARBONE T, Picerno V, Pafundi V, Esposito E, et al
     Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases.
     J Rheumatol. 2021 Oct 15. pii: jrheum.210611. doi: 10.3899/jrheum.210611.
     PubMed     Abstract available
     
     
     
199. GOULENOK T, Francois C, Mendes C, Farhi F, et al
     Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases.
     J Rheumatol. 2021 Oct 15. pii: jrheum.210534. doi: 10.3899/jrheum.210534.
     PubMed     Abstract available
     
     
     
200. SAURET A, Stievenart J, Smets P, Olagne L, et al
     Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?
     J Rheumatol. 2021 Oct 1. pii: jrheum.210724. doi: 10.3899/jrheum.210724.
     PubMed     Abstract available
     
     
     
201. ULLOA AC, Liao F, Carlomagno RL, Dia T, et al
     Schizophrenia Genetics and Neuropsychiatric Features in Childhood-Onset Systemic Lupus Erythematosus.
     J Rheumatol. 2021 Oct 1. pii: jrheum.210363. doi: 10.3899/jrheum.210363.
     PubMed     Abstract available
     
     
     
202. ROSS C, Elfassy HL, Makhzoum JP
     Somatic Mutation in UBA1 and ANCA-associated Vasculitis.
     J Rheumatol. 2021;48:1626-1627.
     PubMed    
     
     
     
203. FERFAR Y, Morinet S, Espitia O, Agard C, et al
     Spectrum and Outcome of Noninfectious Aortitis.
     J Rheumatol. 2021;48:1583-1588.
     PubMed     Abstract available
     
     
     
204. HORNE A, von Bahr Greenwood T, Chiang SCC, Meeths M, et al
     Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
     J Rheumatol. 2021;48:1596-1602.
     PubMed     Abstract available
     
     
     
205. OMAN A, Dicksved J, Engstrand L, Berntson L, et al
     Fecal Microbiota in Untreated Children With Juvenile Idiopathic Arthritis: A Comparison With Healthy Children and Healthy Siblings.
     J Rheumatol. 2021;48:1589-1595.
     PubMed     Abstract available
     
     
     September 2021
206. LIEBER SB, Nahid M, Paget S, Berman JR, et al
     Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus.
     J Rheumatol. 2021 Sep 1. pii: jrheum.201466. doi: 10.3899/jrheum.201466.
     PubMed     Abstract available
     
     
     
207. CLEMENT J, Duffau P, Constans J, Schaeverbeke T, et al
     Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients.
     J Rheumatol. 2021;48:1435-1441.
     PubMed     Abstract available
     
     
     
208. GERSTEIN M, Borgia RE, Dominguez D, Feldman BM, et al
     Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis.
     J Rheumatol. 2021;48:1450-1457.
     PubMed     Abstract available
     
     
     August 2021
209. WANG X, Hefton A, Ni K, Ukadike KC, et al
     Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
     J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
     PubMed     Abstract available
     
     
     
210. FALASINNU T, Drenkard C, Bao G, Mackey S, et al
     The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms.
     J Rheumatol. 2021;48:1279-1289.
     PubMed     Abstract available
     
     
     
211. MOHAMMAD AJ, Turkiewicz A, Stamatis P, Turesson C, et al
     Trajectory of Healthcare Resource Utilization in Giant Cell Arteritis: A Population-based Study.
     J Rheumatol. 2021;48:1307-1313.
     PubMed     Abstract available
     
     
     
212. MANNION ML, Xie F, Horton DB, Ringold S, et al
     Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
     J Rheumatol. 2021;48:1322-1329.
     PubMed     Abstract available
     
     
     July 2021
213. RUPERTO N, Brunner HI, Tzaribachev N, Vega-Cornejo G, et al
     Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2021;48:1073-1081.
     PubMed     Abstract available
     
     
     
214. ZHAO Y, Iyer RS, Thapa M, Biswas D, et al
     A Novel Algorithm using Within-leg Calibration for Enhanced Accuracy of Detection of Arthritis by Infrared Thermal Imaging in Children.
     J Rheumatol. 2021 Jul 1. pii: jrheum.210077. doi: 10.3899/jrheum.210077.
     PubMed     Abstract available
     
     
     
215. WALLACE ZS, Yun H, Curtis JR, Chen L, et al
     ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry.
     J Rheumatol. 2021;48:1060-1064.
     PubMed     Abstract available
     
     
     
216. CRAIG J, Feldman BM, Spiegel L, Dover S, et al
     Comparing the Measurement Properties and Preferability of Patient-reported Outcome Measures in Pediatric Rheumatology: PROMIS vs CHAQ.
     J Rheumatol. 2021;48:1065-1072.
     PubMed     Abstract available
     
     
     
217. SUN K, Eudy AM, Criscione-Schreiber LG, Sadun RE, et al
     Racial Differences in Patient-provider Communication, Patient Self-efficacy, and Their Associations With Systemic Lupus Erythematosus-related Damage: A Cross-sectional Survey.
     J Rheumatol. 2021;48:1022-1028.
     PubMed     Abstract available
     
     
     June 2021
218. SMITHERMAN EA, Cron RQ
     Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus.
     J Rheumatol. 2021 Jun 15. pii: jrheum.210024. doi: 10.3899/jrheum.210024.
     PubMed     Abstract available
     
     
     
219. AL AWQATI MZ, Sluzevich JC, Berianu F
     Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-gamma Antibody.
     J Rheumatol. 2021 Jun 15. pii: jrheum.200399. doi: 10.3899/jrheum.200399.
     PubMed     Abstract available
     
     
     
220. VILLIGER PM
     Giant Cell Arteritis: Real-life Experience.
     J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
     PubMed     Abstract available
     
     
     
221. GROOT N, Kardolus A, Bijl M, Dolhain RJEM, et al
     Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult Life.
     J Rheumatol. 2021;48:915-923.
     PubMed     Abstract available
     
     
     May 2021
222. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
     Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
     J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
     PubMed     Abstract available
     
     
     
223. RAHMAN A
     Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
     J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
     PubMed     Abstract available
     
     
     
224. REZAEI E, Newkirk MM, Li Z, Gordon JR, et al
     Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
     J Rheumatol. 2021;48:760-766.
     PubMed     Abstract available
     
     
     April 2021
225. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
     Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
     J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
     PubMed     Abstract available
     
     
     
226. LANGLEBEN D, Berkson L, Chartrand S
     Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
     J Rheumatol. 2021;48:616-617.
     PubMed    
     
     
     
227. JAYNE D
     Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
     J Rheumatol. 2021;48:479-481.
     PubMed    
     
     
     
228. SCHNEIDER J, Venhoff N, Walz G
     Ruptured Intrarenal Arterial Aneurysm in a Patient With Granulomatosis With Polyangiitis.
     J Rheumatol. 2021;48:615.
     PubMed    
     
     
     
229. GKROUZMAN E, Sevim E, Finik J, Andrade D, et al
     Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
     J Rheumatol. 2021;48:541-547.
     PubMed     Abstract available
     
     
     
230. MENDEL A, Ennis D, Go E, Bakowsky V, et al
     CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.
     J Rheumatol. 2021;48:555-566.
     PubMed     Abstract available
     
     
     
231. LUO Y, Xu J, Jiang C, Krittanawong C, et al
     Trends in the Inpatient Burden of Coronary Artery Disease in Granulomatosis With Polyangiitis: A Study of a Large National Dataset.
     J Rheumatol. 2021;48:548-554.
     PubMed     Abstract available
     
     
     
232. MALLER J, Fox E, Park KT, Paul SS, et al
     Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
     J Rheumatol. 2021;48:567-574.
     PubMed     Abstract available
     
     
     March 2021
233. BERTI A, Specks U
     The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
     J Rheumatol. 2021;48:314-317.
     PubMed    
     
     
     
234. ROBERTSON AD
     What It Means to Me to Have Juvenile Arthritis: One Patient's Definition.
     J Rheumatol. 2021;48:470.
     PubMed    
     
     
     
235. TANG S, Li X, Zhao KY, Zhou Q, et al
     Clinical Characteristics and Prognostic Analysis of Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage.
     J Rheumatol. 2021;48:410-416.
     PubMed     Abstract available
     
     
     
236. ONO N, Inoue Y, Miyamura T, Ueda N, et al
     The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
     J Rheumatol. 2021;48:417-425.
     PubMed     Abstract available
     
     
     February 2021
237. KORKUS D, Gazitt T, Cohen AD, Feldhamer I, et al
     Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study.
     J Rheumatol. 2021;48:207-213.
     PubMed     Abstract available
     
     
     
238. PETRI M, Barr E, Magder LS
     Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.
     J Rheumatol. 2021;48:222-227.
     PubMed     Abstract available
     
     
     
239. WALSCHEID K, Glandorf K, Rothaus K, Niewerth M, et al
     Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany.
     J Rheumatol. 2021;48:262-269.
     PubMed     Abstract available
     
     
     January 2021
240. AGARWAL S
     Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
     J Rheumatol. 2021;48:151.
     PubMed    
     
     
     September 2019
241. BOLLHALDER A, Patcas R, Eichenberger M, Muller L, et al
     Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
     J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168.
     PubMed     Abstract available
     
     
     March 2019
242. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
     Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
     J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.